AMC vs CLOV
AMC: AMC is the world's largest theatrical exhibitor, striving to return to pre-pandemic operational strength through its massive global network of movie theatres. CLOV: Clover Health combines Medicare Advantage insurance with a data-driven, AI-enabled software platform designed to improve primary care outcomes and manage medical costs.
Side-by-side fundamentals
| Metric | AMC | CLOV | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $3.06 | $4.46 | |
| Market cap | $2.7B | $2.4B | |
| Net margin FY2025, SEC XBRL | -13.0% | -4.4% | CLOV higher |
| Gross margin FY2023, SEC XBRL | n/a | +20.4% | |
| Operating margin FY2025, SEC XBRL | -0.4% | -4.4% | AMC higher |
| ROE FY2025, SEC XBRL | n/a | -27.7% | |
| ROA FY2025, SEC XBRL | -7.9% | -15.8% | AMC higher |
| Debt / equity 0 — no debt reported, balance sheet 2026-06-30 | n/a | 0.00 | |
| Revenue growth (YoY) FY2025, SEC XBRL | +4.6% | +40.3% | CLOV higher |
| Revenue CAGR (3y) SEC XBRL | +7.4% | +20.6% | CLOV higher |
| Dividend streak (yrs) SEC XBRL | 1 | 0 | AMC higher |
| Beta as of 2026-09-03 | 1.16 | 0.90 | |
| 1-year return as of 2026-10-30 close | +20.5% | +28.5% | CLOV higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.